Kleem Chaudhary

Corporate Officer/Principal presso CHECKMATE PHARMACEUTICALS, INC.

48 anni

Health Technology

Consumer Services

Profilo

Kleem Chaudhary is currently the President, Chief Executive Officer & Director at Hyku Biosciences, Inc. He is also the Chief Business Officer at Checkmate Pharmaceuticals, Inc. and the Chief Operating Officer at Redona Therapeutics, Inc. Previously, Dr. Chaudhary worked as the Director-Oncology Division at Novartis AG from 2009 to 2016.
He then served as the Senior Director-Business Development & Licensing at Takeda Pharmaceutical Co., Ltd.
from 2016 to 2018.
After that, he was the Head-Business Development & Licensing at Biogen, Inc. from 2018 to 2019.
Dr. Chaudhary holds a doctorate degree from The University of North Carolina at Chapel Hill and an undergraduate degree from The University of Winnipeg.

Posizioni attive di Kleem Chaudhary

Società	Posizione	Inizio
CHECKMATE PHARMACEUTICALS, INC.	Corporate Officer/Principal	01/11/2019
Redona Therapeutics, Inc. Redona Therapeutics, Inc. BiotechnologyHealth Technology Redona Therapeutics, Inc.operates as a biotechnology company focused on the modulation of non- RNA (ncRNA) function to treat cancer and other human diseases. It uses small molecules to modulate expression levels of oncogenes and other proteins of significance in disease. The company was founded by George Daley, Richard Gregory, Frank Slack, and Piotr Sliz and is headquartered in Watertown, MA.	Chief Operating Officer	-

Tutte le posizioni attive di Kleem Chaudhary

Precedenti posizioni note di Kleem Chaudhary

Società	Posizione	Fine
BIOGEN INC.	Corporate Officer/Principal	01/10/2019
TAKEDA PHARMACEUTICAL COMPANY LIMITED	Corporate Officer/Principal	01/01/2018
NOVARTIS AG	Corporate Officer/Principal	01/05/2016

Vedi nel dettaglio l'esperienza di Kleem Chaudhary

Formazione di Kleem Chaudhary

The University of North Carolina at Chapel Hill	Doctorate Degree
The University of Winnipeg	Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Kleem Chaudhary

Relazioni

100 +

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	3
BIOGEN INC.	Health Technology
NOVARTIS AG	Health Technology
TAKEDA PHARMACEUTICAL COMPANY LIMITED	Health Technology

Aziende private	2
Checkmate Pharmaceuticals, Inc. Checkmate Pharmaceuticals, Inc. BiotechnologyHealth Technology Checkmate Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in developing and commercializing proprietary technology to harness the power of the immune system to combat cancer. The firm's product candidate, vidutolimod is a differentiated TLR9 agonist delivered as a biologic virus-like particle designed to trigger the body's innate immune system to attack tumors in combination with other therapies. The company was founded by Arthur M. Krieg and Chuck Yo in July 2015 and is headquartered in Cambridge, MA.	Health Technology
Redona Therapeutics, Inc. Redona Therapeutics, Inc. BiotechnologyHealth Technology Redona Therapeutics, Inc.operates as a biotechnology company focused on the modulation of non- RNA (ncRNA) function to treat cancer and other human diseases. It uses small molecules to modulate expression levels of oncogenes and other proteins of significance in disease. The company was founded by George Daley, Richard Gregory, Frank Slack, and Piotr Sliz and is headquartered in Watertown, MA.	Health Technology